Rare Blood Disorders
Rare blood disorders are seriously debilitating for patients and fatal if not treated effectively. Here we have collated a selection of articles that present the results of the latest research into treatments for thrombotic thrombocytopenic purpura (TTP) and cold agglutinin disease (CAD).
Click through to the relevant pages in order to access the articles.Cold Agglutinin Disease (CAD)
CAD is a rare, chronic autoimmune haemolytic anaemia with potentially acute and chronic consequences, that are driven by C1 activation of the classical complement pathway.
Here you will find a series of CAD educational resources, including peer-reviewed articles discussing the results of clinical trials for the treatment of Cold Agglutinin Disease. Click into the links below for access to the full-text versions of these key articles.View CAD eprintsThrombotic Thrombocytopenic Purpura (TTP)
TTP is one of a group of blood disorders which constitute true medical emergencies. This rare disorder of the blood coagulation system is life-threatening and requires immediate treatment.
Here we present a series of peer-reviewed articles that look at treatment perspectives for managing aTTP. Click into the links below for access to the full-text versions of these key articles.View TTP eprints
